ID   KCC1A_HUMAN             Reviewed;         370 AA.
AC   Q14012; Q3KPF6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-NOV-2010, entry version 110.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I;
DE            Short=CaM-KI;
DE   AltName: Full=CaM kinase I alpha;
DE            Short=CaMKI-alpha;
GN   Name=CAMK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-177, MUTAGENESIS OF
RP   LYS-49 AND THR-177, AND ENZYME REGULATION.
RX   MEDLINE=95369239; PubMed=7641687;
RA   Haribabu B., Hook S.S., Selbert M.A., Goldstein E.G., Tomhave E.D.,
RA   Edelman A.M., Snyderman R., Means A.R.;
RT   "Human calcium-calmodulin dependent protein kinase I: cDNA cloning,
RT   domain structure and activation by phosphorylation at threonine-177 by
RT   calcium-calmodulin dependent protein kinase I kinase.";
RL   EMBO J. 14:3679-3686(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-9.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [4]
RP   PHOSPHORYLATION BY CAMKK1.
RX   MEDLINE=98324451; PubMed=9662074; DOI=10.1159/000025324;
RA   Hsu L.-S., Tsou A.-P., Chi C.-W., Lee C.-H., Chen J.-Y.;
RT   "Cloning, expression and chromosomal localization of human
RT   Ca2+/calmodulin-dependent protein kinase kinase.";
RL   J. Biomed. Sci. 5:141-149(1998).
RN   [5]
RP   PHOSPHORYLATION BY CAMKK2.
RX   MEDLINE=21391903; PubMed=11395482; DOI=10.1074/jbc.M011720200;
RA   Hsu L.-S., Chen G.-D., Lee L.-S., Chi C.-W., Cheng J.-F., Chen J.-Y.;
RT   "Human Ca2+/calmodulin-dependent protein kinase kinase beta gene
RT   encodes multiple isoforms that display distinct kinase activity.";
RL   J. Biol. Chem. 276:31113-31123(2001).
RN   [6]
RP   FUNCTION IN PHOSPHORYLATION OF EIF4G3.
RX   PubMed=14507913; DOI=10.1074/jbc.M308781200;
RA   Qin H., Raught B., Sonenberg N., Goldstein E.G., Edelman A.M.;
RT   "Phosphorylation screening identifies translational initiation factor
RT   4GII as an intracellular target of Ca(2+)/calmodulin-dependent protein
RT   kinase I.";
RL   J. Biol. Chem. 278:48570-48579(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-217 AND LYS-361.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to
CC       a proposed calcium-triggered signaling cascade involved in a
CC       number of cellular processes like transcriptional regulation,
CC       hormone production, translational regulation, regulation of actin
CC       filament organization and neurite outgrowth. Involved in calcium-
CC       dependent activation of the ERK pathway (By similarity).
CC       Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-
CC       x(3)-[MVLIF]. Phosphorylates EIF4G3/eIF4GII. In vitro
CC       phosphorylates CREB1, ATF1, CTFR, MYL9, SYN1/synapsin I and
CC       SYNII/synapsin II (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in a conformational change that generates
CC       functional binding sites for both, substrate and ATP, and thus
CC       releaves intrasteric autoinhibition. Must be phosphorylated to be
CC       maximally active. Phosphorylated by CAMKK1 or CAMKK2.
CC   -!- SUBUNIT: Monomer. Interacts with XPO1 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Note=Predominantly cytoplasmic (By similarity).
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and interacts in the inactive folded state with the
CC       catalytic domain as a pseudosubstrate (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41816; AAA99458.1; -; mRNA.
DR   EMBL; BC106754; AAI06755.1; -; mRNA.
DR   EMBL; BC106755; AAI06756.1; -; mRNA.
DR   IPI; IPI00028296; -.
DR   PIR; S57347; S57347.
DR   RefSeq; NP_003647.1; -.
DR   UniGene; Hs.434875; -.
DR   ProteinModelPortal; Q14012; -.
DR   SMR; Q14012; 10-316.
DR   STRING; Q14012; -.
DR   PhosphoSite; Q14012; -.
DR   PeptideAtlas; Q14012; -.
DR   PRIDE; Q14012; -.
DR   Ensembl; ENST00000256460; ENSP00000256460; ENSG00000134072.
DR   GeneID; 8536; -.
DR   KEGG; hsa:8536; -.
DR   NMPDR; fig|9606.3.peg.22087; -.
DR   UCSC; uc003bst.1; human.
DR   CTD; 8536; -.
DR   GeneCards; GC03M009774; -.
DR   H-InvDB; HIX0200512; -.
DR   HGNC; HGNC:1459; CAMK1.
DR   HPA; CAB031904; -.
DR   MIM; 604998; gene.
DR   PharmGKB; PA26048; -.
DR   eggNOG; prNOG07976; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q14012; -.
DR   OMA; GNTAYTH; -.
DR   OrthoDB; EOG9N5ZGB; -.
DR   PhylomeDB; Q14012; -.
DR   BRENDA; 2.7.11.17; 247.
DR   NextBio; 31972; -.
DR   ArrayExpress; Q14012; -.
DR   Bgee; Q14012; -.
DR   CleanEx; HS_CAMK1; -.
DR   Genevestigator; Q14012; -.
DR   GermOnline; ENSG00000134072; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0051149; P:positive regulation of muscle cell differen...; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR015734; Ca/CaM-dep_prot_kinase1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF34; CaMKI; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; ATP-binding; Calmodulin-binding; Complete proteome;
KW   Cytoplasm; Developmental protein; Differentiation;
KW   Direct protein sequencing; Kinase; Neurogenesis; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    370       Calcium/calmodulin-dependent protein
FT                                kinase type 1.
FT                                /FTId=PRO_0000086076.
FT   DOMAIN       20    276       Protein kinase.
FT   NP_BIND      26     34       ATP (By similarity).
FT   REGION      276    316       Autoinhibitory domain (By similarity).
FT   REGION      296    317       Calmodulin-binding (By similarity).
FT   MOTIF       315    321       Nuclear export signal (By similarity).
FT   ACT_SITE    141    141       Proton acceptor (By similarity).
FT   BINDING      49     49       ATP.
FT   MOD_RES     177    177       Phosphothreonine; by CaMKK1 and CaMKK2.
FT   VARIANT     217    217       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040596.
FT   VARIANT     361    361       E -> K (in dbSNP:rs56033923).
FT                                /FTId=VAR_040597.
FT   MUTAGEN      49     49       K->A: Loss of activity.
FT   MUTAGEN     177    177       T->A: Loss of activation by CaMKK1.
FT   MUTAGEN     177    177       T->D: Partial activation in absence of
FT                                CAMKK1.
SQ   SEQUENCE   370 AA;  41337 MW;  57FA20ECE00FA76C CRC64;
     MLGAVEGPRW KQAEDIRDIY DFRDVLGTGA FSEVILAEDK RTQKLVAIKC IAKEALEGKE
     GSMENEIAVL HKIKHPNIVA LDDIYESGGH LYLIMQLVSG GELFDRIVEK GFYTERDASR
     LIFQVLDAVK YLHDLGIVHR DLKPENLLYY SLDEDSKIMI SDFGLSKMED PGSVLSTACG
     TPGYVAPEVL AQKPYSKAVD CWSIGVIAYI LLCGYPPFYD ENDAKLFEQI LKAEYEFDSP
     YWDDISDSAK DFIRHLMEKD PEKRFTCEQA LQHPWIAGDT ALDKNIHQSV SEQIKKNFAK
     SKWKQAFNAT AVVRHMRKLQ LGTSQEGQGQ TASHGELLTP VAGGPAAGCC CRDCCVEPGT
     ELSPTLPHQL
//
